Vaccine developer Medicago (TSX:MDG) will target rotavirus, the leading cause of diarrhea in infants and children worldwide, under a new partnership with Japanese firm Mitsubishi Tanabe Pharma. Medicago stands to gain nearly $33 million in payments from Mitsubishi Tanabe under the vaccine collaboration and development deal, plus royalties on future sales of a new rotavirus […]
Vaccine maker Medicago (TSX:MDG) has developed a technology that can turn tobacco leaves into vaccines quickly and inexpensively, and the biotechnology company’s new North Carolina site stands ready for influenza vaccine production. But when Medicago unveiled its new Research Triangle Park facility last November amid great fanfare, CEO Andrew Sheldon said he couldn’t disclose Medicago’s […]
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
Biotechnology company Medicago (TSX:MDG), whose technology makes vaccines from tobacco leaves, now has an additional $11.1 million from an investor who knows a thing or two about the golden leaf: Philip Morris (NYSE:PM). Medicago shareholders approved the investment, the second tranche of a $22.5 million private placement with the tobacco giant. Philip Morris is acquiring […]
Biotechnology company Medicago (TSX:MDG) now has a facility that needs just 30 days to turn into new flu vaccine the plant that has been the cornerstone of North Carolina’s economy for hundreds of years. Medicago makes vaccine from the leaves of tobacco plants. The Quebec City, Canada company formally opened its new plant in Research […]
Biotechnology company Medicago (TSX:MDG) could soon demonstrate whether its technology can rapidly develop and manufacture vaccines to respond to potential pandemic and bioterror threats. Medicago, which is part of a national project to develop vaccine capabilities to respond to virus threats, has launched operations in its Research Triangle Park, North Carolina facility. The company expects […]
New flu vaccines made from tobacco plants could soon be made in Research Triangle Park, North Carolina. Vaccine company Medicago has received a $3.8 million milestone payment for its progress toward completing its new vaccine facility.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.